Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
GBP 116M - 116M
Notice Type:
Contract award notice
Published Date:
08 November 2016
Closing Date:
Location(s):
UK UNITED KINGDOM
Description:

NHS Generic Pharmaceuticals Wave 10b

Offer reference number: CM/PHG/15/5465

Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 48 months

Potential periods of call-offs under the framework agreement:

100 % products:

All regions: 1.11.2016 to 28.2.2019 (28 months)

33 % products:

DCE & DSW: 01/11/2016 to 30/06/2018 (20 months)

Housekeeping:

DLS & DNE: 1.11.2016 to 30.6.2017 (8 months);

DLN & DNW: 1.11.2016 to 30.6.2017 (8 months).

The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England.

The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Document 10 in the Invitation To Offer Documents for the list of Purchasing Points.


Wave 10b

NHS Generic Pharmaceuticals Wave 10b

CM/PHG/15/5465

Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 48 months

Potential periods of call-offs under the framework agreement:

100 % products: All regions: 1.11.2016 to 28.2.2019 (28 months)

33 % products: DCE & DSW: 1.11.2016 to 30.6.2018 (20 months)

Housekeeping:

DLS & DNE: 1.11.2016 to 30.6.2017 (8 months)

DLN & DNW: 1.11.2016 to 30.6.2017 (8 months)

The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above.

Please refer to Document 10 in the Invitation To Offer Documents for the list of Purchasing Points.


Wave 10b

NHS Generic Pharmaceuticals Wave 10b

CM/PHG/15/5465

Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 48 months

Potential periods of call-offs under the framework agreement:

100 % products: All regions: 1.11.2016 to 28.2.2019 (28 months)

33 % products: DCE & DSW: 1.11.2016 to 30.6.2018 (20 months)

Housekeeping:

DLS & DNE: 1.11.2016 to 30.6.2017 (8 months)

DLN & DNW: 1.11.2016 to 30.6.2017 (8 months)

The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above.

Please refer to Document 10 in the Invitation To Offer Documents for the list of Purchasing Points.

Awarded to:
Generic Pharmaceuticals Wave 10b
Please see Section VI.3), Please see Section VI.3) (UK)
Download full details as .pdf
The Buyer:
The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health)
CPV Code(s):
33600000 - Pharmaceutical products
33690000 - Various medicinal products